FDA Inspection 1100574 — AbbVie Deutschland GmbH & Co. KG
The FDA completed an inspection of AbbVie Deutschland GmbH & Co. KG on July 19, 2019 in Ludwigshafen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ludwigshafen (Germany)